Not available
Quote | Edge Therapeutics Inc. (NASDAQ:EDGE)
Last: | $ |
---|---|
Change Percent: | 11.42% |
Open: | $0.46 |
Close: | $0.5036 |
High: | $0.57 |
Low: | $0.440984 |
Volume: | 1,122,710 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Edge Therapeutics Inc. (NASDAQ:EDGE)
Edge Therapeutics (NASDAQ: EDGE ): FY GAAP EPS of -$1.31. More news on: Edge Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
BERKELEY HEIGHTS, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the full-year ended December 31, 2018. Financial Results Cash Position: Cash and cash equivalents totaled $34.6 million at December 31, 2018, compa...
Message Board Posts | Edge Therapeutics Inc. (NASDAQ:EDGE)
Subject | By | Source | When |
---|---|---|---|
https://investorshub.advfn.com/boards/board.aspx?board_id=38052 | Bertsllc | investorshub | 07/20/2020 7:30:36 PM |
EDGE Failed phase 3 clinical trial and folded. | Bertsllc | investorshub | 07/20/2020 7:22:06 PM |
Why isn't there a PDSB Forum here on IHUB? | Smilin_B | investorshub | 04/03/2019 2:43:45 PM |
Ahhh thank u. How did the stock | Smilin_B | investorshub | 04/03/2019 2:42:22 PM |
moved to pdsb | jpowellvlc | investorshub | 04/03/2019 2:20:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Edge Therapeutics Inc. Company Name:
EDGE Stock Symbol:
NASDAQ Market:
BERKELEY HEIGHTS, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the full-year ended December 31, 2018. Financial Results Cash Position: Cash and cash equivalents totaled $34.6 million at December 31, 2018, compa...
BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the quarter ended September 30, 2018. Third Quarter Financial Results Cash Position: Cash, cash equivalents and marketable securities as of Septemb...